0.00Open0.05Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover2146.84%IV20.85%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier-6DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.2167Delta0.6565Gamma42.20Leverage Ratio-1.7676Theta0.0000Rho9.14Eff Leverage0.0001Vega
LAVA Therapeutics Stock Discussion
LAVA Therapeutics N.V., a leader in the biotechnology sector, has recently announced a significant clinical development milestone achieved by Pfizer for the drug PF-08046052. This milestone has prompted the first payment of $7 million to LAVA, marking a notable event in the field of immuno-oncology. $LAVA Therapeutics(LVTX.US)$
https://stockregion.app/p/biotech-leader-announces-7m-milestone
No comment yet